Skip to main content
SpringerLink
Log in

New islets from old

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Transplantation of pancreatic islet cells could provide a cure for diabetes. However, it has been difficult to obtain sufficient numbers of purified islets from a single cadaver pancreas. Stem cell technology may someday overcome this limitation, and may also make possible the use of autologous tissues (278–282).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stratta, R.J., Taylor, R.J., Larsen, J.L. & Cushing, K. Pancreas transplantation. Ren. Fail. 17, 323–337 (1995).

    Article  CAS  Google Scholar 

  2. Cretin, N. et al. Human islet allotransplantation: world experience and current status. Dig. Surg. 15, 656– 662 (1998).

    Article  CAS  Google Scholar 

  3. Ramiya, V.K. et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Med. 6, 278–282 (2000).

    Article  CAS  Google Scholar 

  4. Jackson, K.A., Mi, T. & Goodell, M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA 96, 14482–14486 (1999).

    Article  CAS  Google Scholar 

  5. Petersen, B.E. et al. Bone marrow as a potential source of hepatic oval cells. Science 28, 1168–1170 ( 1999).

    Article  Google Scholar 

  6. Beattie, G.M. et al. Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes 48, 1013– 1019 (1999).

    Article  CAS  Google Scholar 

  7. Soria, B. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157–161 (2000).

    Article  CAS  Google Scholar 

  8. Montana, E., Bonner-Weir, S. & Weir, G.C. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J. Clin. Invest. 91, 780–787 (1993).

    Article  CAS  Google Scholar 

  9. Juang, J.H., Bonner-Weir, S., Wu, Y.J. & Weir, G.C. Beneficial influence of glycemic control upon the growth and function oftransplanted islets. Diabetes 43, 1334– 1339 (1994).

    Article  CAS  Google Scholar 

  10. Ohzato, H., Porter, J., Monaco, A.P., Montana, E., Maki, T. Minimum number of islets required to maintain euglycemia and their reduced immunogenicity after transplantation into diabetic mice. Transplantation 56, 270–274 ( 1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Division, Joslin Diabetes Center One Joslin Place, Boston, 02215, Massachusetts, USA

    David H. Sachs

  2. Transplantation Biology Research Center Massachusetts General Hospital Bldg, 149–9019, 13th Street, Boston, 02129, Massachusetts, USA

    Susan Bonner-Weir

Authors
  1. David H. Sachs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan Bonner-Weir
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sachs, D., Bonner-Weir, S. New islets from old. Nat Med 6, 250–251 (2000). https://doi.org/10.1038/73079

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/73079

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation